{"id":7167,"date":"2022-03-29T07:53:11","date_gmt":"2022-03-29T05:53:11","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2022\/03\/220328_FR_MaaT-Pharma_CP-Lancement-Phase-3-VF-2.pdf"},"modified":"2022-03-29T07:53:11","modified_gmt":"2022-03-29T05:53:11","slug":"220328_fr_maat-pharma_cp-lancement-phase-3-vf-2-2","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/220328_fr_maat-pharma_cp-lancement-phase-3-vf-2-2\/","title":{"rendered":"220328_FR_MaaT-Pharma_CP-Lancement-Phase-3-VF-2"},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-7167","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n